Get the Stockscreener App
47.33
4.46%
2.02
After Hours:
49.18
1.85
+3.91%
Twist Bioscience Corp stock is traded at $47.33, with a volume of 502.20K.
It is up +4.46% in the last 24 hours and down -6.48% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$45.31
Open:
$45.34
24h Volume:
502.20K
Relative Volume:
0.68
Market Cap:
$2.81B
Revenue:
$277.49M
Net Income/Loss:
$-192.14M
P/E Ratio:
-14.09
EPS:
-3.36
Net Cash Flow:
$-95.52M
1W Performance:
-1.73%
1M Performance:
-6.48%
6M Performance:
-1.40%
1Y Performance:
+45.50%
1-Day Range:
$45.10
$47.84
1-Week Range:
$44.59
$47.85
52-Week Range:
$27.41
$60.90
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
47.33 | 2.81B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience Co. (NASDAQ:TWST) Stock Holdings Lessened by JPMorgan Chase & Co. - Defense World
Companies Like Twist Bioscience (NASDAQ:TWST) Can Afford To Invest In Growth - Yahoo Finance
Principal Financial Group Inc. Increases Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) Director Sells 3,504 Shares of Stock - MarketBeat
Twist Bioscience director Robert Chess sells $181,696 in stock - Investing.com
Twist Bioscience Co. (NASDAQ:TWST) Shares Bought by Stifel Financial Corp - Defense World
All You Need to Know About Twist Bioscience (TWST) Rating Upgrade to Buy - Yahoo Finance
Twist Bioscience’s SVP sells stock for $12,662 By Investing.com - Investing.com Nigeria
Dennis Cho Sells 316 Shares of Twist Bioscience Co. (NASDAQ:TWST) Stock - MarketBeat
Twist Bioscience Co. (NASDAQ:TWST) CEO Emily M. Leproust Sells 1,654 Shares - MarketBeat
Twist Bioscience exec sells $14,189 in stock - Investing.com
Twist Bioscience's SVP sells stock for $12,662 - Investing.com
Twist Bioscience CEO Emily Leproust sells $74,269 in stock - Investing.com
Twist Bioscience exec sells $14,189 in stock By Investing.com - Investing.com Canada
Twist Bioscience (TWST) Surges 9.9%: Is This an Indication of Further Gains? - Yahoo Finance
Twist Bioscience Co. (NASDAQ:TWST) Shares Bought by Geode Capital Management LLC - MarketBeat
Twist Bioscience (NASDAQ:TWST) Trading 8% HigherShould You Buy? - MarketBeat
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Interesting TWST Put And Call Options For July 2025 - Nasdaq
Lord Abbett & CO. LLC Cuts Stake in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Co. (NASDAQ:TWST) Receives $51.90 Consensus Target Price from Brokerages - Defense World
Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Twist Bioscience's SWOT analysis: DNA storage advances boost stock outlook - Investing.com
Twist Bioscience Co. (NASDAQ:TWST) Receives $51.90 Consensus Target Price from Analysts - MarketBeat
State Street Corp Acquires 526,028 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Wellington Management Group LLP Acquires 521,272 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Wolfe Research Begins Coverage on Twist Bioscience (NASDAQ:TWST) - MarketBeat
Fmr LLC Increases Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Is Alvotech (ALVO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Why Twist Bioscience (TWST) Is the Worst ARK Stock to Buy According to Short Sellers - Insider Monkey
Twist Bioscience Co. (NASDAQ:TWST) Stake Lessened by Castleark Management LLC - MarketBeat
Benjamin Edwards Inc. Has $572,000 Stake in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Verition Fund Management LLC Purchases 19,054 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
BNP Paribas Financial Markets Boosts Stake in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Corp (TWST) Stock Price Up 3.42% on Dec 4 - GuruFocus.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $39.77 Million Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience stock gets Outperform rating from Baird, pricing premiums remain elevated - Investing.com
Twist Bioscience: Path To Profitability Beginning To Take Shape (NASDAQ:TWST) - Seeking Alpha
Dynamic Technology Lab Private Ltd Takes $599,000 Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Algert Global LLC Purchases 16,292 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Massachusetts Financial Services Co. MA Purchases 20,035 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience's chief accounting officer sells shares worth $34,870 By Investing.com - Investing.com Canada
Twist Bioscience's chief accounting officer sells shares worth $34,870 - Investing.com
Twist Bioscience named a Best Idea for 2025 at TD Cowen - Yahoo Finance
Is Agios Pharmaceuticals (AGIO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Twist Bioscience shares hold Buy rating, price target on solid guidance - Investing.com
Twist Bioscience's SWOT analysis: DNA storage innovation propels stock outlook - Investing.com
Leerink Partnrs Issues Positive Forecast for TWST Earnings - Defense World
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Twist Bioscience Co. (NASDAQ:TWST) Receives $51.22 Average Target Price from Brokerages - Defense World
Q1 EPS Forecast for Twist Bioscience Increased by Analyst - MarketBeat
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):